The LBDA Industry Advisory Council (IAC)

LBDA is committed to engaging research stakeholders across all sectors. In 2019 LBDA formed an Industry Advisory Council (IAC) to convene leaders in the LBD academic medical/scientific community, federal agencies and biotech companies with the aim of advancing the study of diagnostic tools and potential treatments for LBD.

Benefits of Membership

Corporate membership in LBDA’s Industry Advisory Council is fee-based and available at 3 levels. Members receive recognition to LBDA’s Scientific Advisory Council, the LBDA Research Centers of Excellence (RCOE) network and the LBD community. The benefits for corporate membership may include:

  • Invitation to IAC meetings.
  • Consult meetings with key scientific advisors.
  • Opportunities to present data to LBD researchers and clinicians.
  • Access to RCOE site capabilities data.
  • Discount on fee for service projects.
  • Acknowledgment on LBDA’s website.

If you are interested in learning more about the Industry Advisory Council, please contact Angela Taylor at

Current IAC Members:

Acadia Eisai Eli Lilly